Bayer Shareholders Approve Lanxess Spin Off Plan
Leverkusen, Germany, November 30--At an extraordinary general meeting on Wednesday, the majority of shareholders in Bayer, the German chemicals and pharmaceuticals company, voted in favour of a spin-off of Lanxess.